Skip to main content

Table 2 Laboratory data of 37 patients with ACL before and after specific treatment

From: Renal function evaluation in patients with American Cutaneous Leishmaniasis after specific treatment with pentavalent antimonial

 

Pre-treatment

Post-treatment

 P 

Hematocrit (%)

42.6 ± 4.1

40.5 ± 4.2

0.0052

Hemoglobin (g/%)

13.9 ± 1.2

13.3 ± 1.5

0.019

White blood count (/mm 3 )

6.359 ± 1918

6.035 ± 1513

0.269

Platelets (/mm 3 )

275.351 ± 66.259

292.702 ± 60.570

0.074

Arterial pH

7.35 ± 0.1

7.35 ± 0.1

0.634

Fasting glucose (mg/dl)

80 ± 15

80 ± 17

0.915

Amylase (U/dl)

143 ± 48

148 ± 62

0.666

Total Bilirubin (mg/dl)

0.5 ± 0.27

0.6 ± 0.23

0.810

Alkaline Phosphatase (U/L)

93 ± 33

107 ± 52

0.08

Albumin (g/dl)

4 ± 0.6

4 ± 0.6

0.696

Globulin (g/dl)

3.3 ± 0.86

3.3 ± 0.7

0.135

AST (g/dl)

34 ± 15

46 ± 36

0.034

ALT (U/L)

28 ± 19

42 ± 33

0.023

ESR (mm/h)

30 ± 21

26 ± 18

0.198

  1. Significant P < 0.05. AST: aspartate aminotransferase; ALT: alanine aminotransferase; ESR: erythrocyte sedimentation rate. Data expressed as mean ± standard deviation or %. T test and Wilcoxon test.
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us